Detalhe da pesquisa
1.
Rapid home therapy infusion of velaglucerase alfa in naïve patients with Gaucher disease.
Intern Med J
; 54(3): 398-403, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37493453
2.
A Comprehensive Assessment of Qualitative and Quantitative Prodromal Parkinsonian Features in Carriers of Gaucher Disease-Identifying Those at the Greatest Risk.
Int J Mol Sci
; 23(20)2022 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36293067
3.
The Effect of Nutritional Therapy on Bone Mineral Density and Bone Metabolism in Pediatric Crohn Disease.
J Pediatr Gastroenterol Nutr
; 72(6): 877-882, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33587407
4.
Comparison of Bone Mineral Density by Dual-Energy X-Ray Absorptiometry and Bone Strength by Speed-of-Sound Ultrasonography in Adults With Gaucher Disease.
J Clin Densitom
; 19(4): 465-470, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26781431
5.
Bone mineral density and lean muscle mass characteristics in children with Gaucher disease treated with enzyme replacement therapy or untreated.
Blood Cells Mol Dis
; 68: 135-138, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27847274
6.
Booster-effect with velaglucerase alfa in patients with Gaucher disease switched from long-term imiglucerase therapy: early Access Program results from Jerusalem.
Blood Cells Mol Dis
; 48(1): 45-50, 2012 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22047948
7.
Organ volume by computed tomography correlates with longitudinal axis on ultrasound in patients with Gaucher disease.
Ultrasound Q
; 27(4): 225-8, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22124387